McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Leadership Edge with Andrew Dudum, Co-Founder and CEO of Hims & Hers: A Modern Approach to Health and Wellness

by McKesson Ventures | Apr 29, 2021 | Portfolio News

Andrew Dudum is more than just the co-founder and CEO of Hims & Hers. He is also an active angel investor and advisor to more than two dozen startups. In a recent interview with Thrive Global, Dudum talked about his past career, what makes Hims & Hers unique,...

Wellness brand Hims & Hers moving deeper into healthcare with Privia Health partnership

by McKesson Ventures | Jan 20, 2021 | Portfolio News

Hims launched in 2017 as a men’s health company, selling just a few products designed to help men suffering from erectile dysfunction or hair loss. Now the company has expanded greatly, adding a women’s health business called Hers, focused on birth control, sexual...

Hims & Hers Health, Inc. Closes Business Combination and Wil Begin Trading on the New York Stock Exchange

by McKesson Ventures | Jan 20, 2021 | Press Releases

Hims & Hers Health Inc (“Hims & Hers”), a multi-specialty telehealth platform, announced that it has closed its business combination with Oaktree Acquisition Corp., a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management....

Andrew Dudum, Hims & Hers, on disrupting healthcare by reimagining the patient experience

by McKesson Ventures | Jan 7, 2021 | Portfolio News

On a recent episode of Wharton Digital Health’s The Pulse podcast, Hims & Hers Founder and CEO Andrew Dudum discussed a wide range of topics including how Hims & Hers disrupted the $4 trillion healthcare industry by creating a telehealth tool that makes...

Coronavirus Home Tests: How They Work, What They Cost, and How Accurate They Are

by McKesson Ventures | Oct 2, 2020 | Portfolio News

The shortage of COVID-19 tests has become an ongoing problem in the U.S. The shortages of test kits and testing supplies, combined with lack of access to physical testing sites, contributed to the lack of coronavirus testing nationwide and the spread of infection...
Page 3 of 6«12345...»Last »

Recent Posts

  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings